je.st
news
Celgene Co. (CELG) Upgraded to Strong-Buy at Vetr Inc.
2015-12-31 18:25:53| Biotech - Topix.net
The firm presently has a $133.83 price objective on the biopharmaceutical company's stock. Vetr 's price target points to a potential upside of 10.90% from the company's current price.
Tags: inc
upgraded
celgene
celg
Category:Biotechnology and Pharmaceuticals